Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From CareDx, Inc.

IPO Gives Kyverna Cash To Maintain Lead In Autoimmune CAR-T Development

Kyverna CEO Peter Maag spoke with Scrip about the company’s five-year overnight success after its well-received IPO. Metagenomi and Telomir also went public in the US in smaller offerings.

Financing Strategy

Minute Insight: CareDx Enters Donor Organ Procurement Market With MediGO Acquisition

MediGo extends CareDX’s digital product lineup while expanding its reach into the organ procurement organization market.

Buying The Most Time: CareDx’s Diagnostics For Transplant Recipients

An organ transplant is not a “one and done” procedure, and patients require lifelong post-operative monitoring. Medtech Insight spoke to CareDx about how monitoring could improve patient outcomes.

Commercial Platform Technologies

Deals Shaping the Medical Industry, October 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.

Deals BioPharmaceutical
See All

Company Information

  • Other Names / Subsidiaries
    • XDx, ImmuMetrix, Inc.
UsernamePublicRestriction

Register